Last reviewed · How we verify
Arnicare Leg Cramps (COPPER)
At a glance
| Generic name | COPPER |
|---|---|
| Sponsor | Sebela Womens Hlth |
| Drug class | Copper-containing Intrauterine Device [EPC] |
| Modality | Small molecule |
| Therapeutic area | Pain |
| Phase | FDA-approved |
| First approval | 2026 |
Approved indications
- nighttime cramps in legs
- nighttime cramps in thighs
- nighttime cramps in calves
- nighttime cramps in feet
- nighttime cramps in toes
- disrupted sleep
Common side effects
Key clinical trials
- Postpartum Family Planning Program in Rwanda (NA)
- Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas (PHASE1)
- Copper Supplementation in Cirrhosis (NA)
- A Phase 1/2/3 Study of UX701 Gene Therapy in Adults With Wilson Disease (PHASE1,PHASE2)
- A Study of Tetrathiomolybdate (TM) Plus Capecitabine (PHASE1,PHASE2)
- NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. (PHASE1)
- Exchangeable and Relative Exchangeable Copper as an Alternative to 24-Hour Urinary Copper in Wilson's Disease Monitoring
- Off Treatment Urinary Copper Excretion in Wilson Disease, Pilot Study
Patents
| Patent | Expiry | Type |
|---|---|---|
| 10398588 | 2034-02-24 | Formulation |
| 9610191 | 2034-02-24 | Method of Use |
| 9265652 | 2034-04-28 | Method of Use |
| 9427351 | 2032-08-14 | Formulation |
| 11850181 | 2032-08-14 | Formulation |
| 10918516 | 2037-01-23 | Formulation |
| 10188546 | 2032-08-14 | Formulation |
| 11207209 | 2034-08-16 | Formulation |
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
| FDA Orange Book | Patents + exclusivity |